1. Baker, D.K., M.V. Relling, C.H. Pui, W.E. Evans and J.H. Rodman. Increased Teniposide clearance with concomitant anticonvulsant therapy. Journal of Clinical Oncology 10:311-315, 1992.
  2. Bartlett, A., A. Costa, L. Martinez, R. Roser, R. Sagarra and J. Sanchez. The effect of antacid and Ranitidine on droxicam pharmacokinetics. Journal of Clinical Pharmacology 32:1115-1119, 1992.
  3. Bayard, D.S. Reduced complexity dynamic programming based on policy iteration. Journal of Mathematical Analysis and Applications 170:75-103, 1992.
  4. Cardoso, P.F.G., M. Spino, E. Mayer, S.Q. Shi, R.D. Pop, J. Puskas, D. Perrier, J. Tong, A.D. Baines and G.A. Patterson. Use of an isolated in situ canine lung perfusion model to evaluate dopamine clearance by the lung. Journal of Pharmacology and Experimental Therapeutics 259:1271-1276, 1992.
  5. Conley, B.A., M.J. Egorin, V. Sinibaldi, G. Sewack, C. Kloc, L. Roberts, E.G. Zuhowski, A. Forrest and D.A. Vanecho. Approaches to optimal dosing of hexamethylene bisacetamide (NSC 95580). Cancer Chemotherapy and Pharmacology 31:37-45, 1992.
  6. Cook, C.E., A.R. Jeffcoat, B.M. Sadler, J.M. Hill, R.D. Voyksner, D.E. Pugh, W.R. White and M. Perezreyes. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metabolism and Disposition 20:856-862, 1992.
  7. Cooper, M. and C. Myers. Suramin for prostate carcinoma reply. Journal of Clinical Oncology 10:1985-1986, 1992.
  8. Coxson, P.G., E.M. Salmeron, R.H. Huesman and B.M. Mazoyer. Simulation of compartmental models for kinetic data from a positron emission tomograph. Computer Methods and Programs in Biomedicine 37:205-214, 1992.
  9. de Valeriola, D.L., D.D. Ross, A. Forest, D.P. Cuddy and M.J. Egorin. Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs. Cancer Chemotherapy and Pharmacology 29:133-140, 1992.
  10. Drusano, G.L., G.J. Yuen, J.S. Lambert, M. Seidlin, R. Dolin and F.T. Valentine. Relationship between dideoxyinosine exposure, CD4 counts, and P24 antigen levels in human immunodeficiency virus infection – a phase I trial. Annals of Internal Medicine 116:562-566, 1992.
  11. Duddu, S.P. and D.J.W. Grant. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state. Pharmaceutical Research 9:1083-1091, 1992.
  12. Errecalde, J.O. and M.F. Landoni. The pharmacokinetics of a slow release theophylline preparation in horses after intravenous and oral administration.Veterinary Research Communications 16:131-138, 1992.
  13. Evans, W.E., J.H. Rodman, M.V. Relling, W.P. Petros, C.F. Stewart, C.H. Pui and G.K. Rivera. Differences in teniposide disposition and pharmacodynamics of leukopenia in patients with newly diagnosed and relapsed acute lymphocytic leukemia. Journal of Experimental Therapeutics 260:71-77, 1992.
  14. Fletcher, C.V., F.S. Rhame, C.C. Beatty, M. Simpson and H.H. Balfour. Comparative pharmacokinetics of Zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease. Pharmacotherapy 12:429-434, 1992.
  15. Garciaagundez, M.J., C. Fernandezlastra, R. Jimenez, J. Gonzalez and E.L. Marino. Pharmacokinetic parameters from data relating to the plasma and biliary excretion kinetics of Cefmetazole in rats. European Journal of Drug Metabolism and Pharmacokinetics 17:167-173, 1992.
  16. Houghton, P.J., P.J. Cheshire, L. Myers, C.F. Stewart, T.W. Synold and J.A. Houghton. Evaluation of 9-Dimethylaminomethyl-10-Hydroxycamptothecin against xenografts derived from adult and childhood solid tumors. Cancer Chemotherapy and Pharmacology 31:229-239, 1992.
  17. Jodrell, D.I., M.J. Egorin, R.M. Canetta, P. Langenberg, E.P. Goldbloom, J.N. Burroughs, J.L. Goodlow, S. Tan and E. Wiltshaw. Relationships between Carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. Journal of Clinical Oncology 10:520-528, 1992.
  18. Kauffman, R.E. and G.L. Kearns. Pharmacokinetic studies in pediatric patients clinical and ethical considerations. Clinical Pharmacokinetics 23:10-29, 1992.
  19. Lettieri, J.T., M.C. Rogge, L. Kaiser, R.M. Echols and A.H. Heller. Pharmacokinetic profiles of Ciprofloxacin after single intravenous and oral doses. Antimicrobial Agents and Chemotherapy 36: 993-996, 1992.
  20. Madden, T. The pharmacokinetics and pharmacodynamics of Etoposide administered as a continuous infusion. Journal of Informative Chemotherapy 2:164-168, 1992.
  21. Madden, T., M. Sunderland, V. Santana and J.H. Rodman. The pharmacokinetics of high dose Carboplatin in pediatric cancer patients. Clinical Pharmacology Therapeutics 51:701-707, 1992.
  22. Marino, A.T., J.J. Distefano and E.M. Landaw. Dimsum – an expert system for multiexponential model discrimination. American Journal of Physiology 262:E546-E556, 1992.
  23. Motzer, R.J., D.M. Nanus, P. Omoore, H.I. Scher, D.F. Bajorin, V. Reuter, W.P. Tong, J. Iversen, C. Louison, A.P. Albino and G.J. Bosl. Phase II trial of Suramin in patients with advanced renal cell carcinoma treatment results, pharmacokinetics, and tumor growth factor expression. Cancer Research 52:5775-5779, 1992.
  24. Robieux, I., P. Dorian, J. Klein, D. Chung, D. Zborowskasluis, R. Ogilvie and G. Koren. The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics. Journal of Clinical Pharmacology 32:338-343, 1992.
  25. Scher, H.I., D.I. Jodrell, J.M. Iversen, T. Curley, W. Tong, M.J. Egorin and A. Forrest. Use of adaptive control with feedback to individualize suramin dosing. Cancer Research 52:64-70, 1992.
  26. Stute, N., V.M. Santana, J.H. Rodman, M.J. Schell, H.N. Ihle and W.E. Evans. Pharmacokinetics of subcutaneous recombinant human granulocyte colony stimulating factor. Blood 79:2849-2854, 1992.
  27. Thomson, A.H. and B. Whiting. Bayesian parameter estimation and population pharmacokinetics. Clinical Pharmacokinetics 22:447-467, 1992.
  28. Wilkes, L., L.H. Danziger and K.A. Rodvold. Phenobarbital pharmacokinetics in obesity – a case report. Clinical Pharmacokinetics 22:481-484, 1992.
  29. Woodworth, J.R., E.H. Nyhart, G.L. Brier, J.D. Wolny and H.R. Black. Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers. Antimicrobial Agents and Chemotherapy 36:318-325, 1992.